Sign in to view content

Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial

Rajiv Anand, MD, FRCS, FASRS

Video
Published 2024

Related

Episode 3: 5-year Results of Argus II Retina Prosthesi with Dr. Rob Devenyi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
On Demand Cases, Courses, and Papers
2021
AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial
Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS
Updates from the Field
2020

Category: Hereditary Retinal Disease & Genetics

See more